Firms

Parkwalk Advisors

Parkwalk Advisors

London, United Kingdom

UK investment manager specialising in companies that commercialise research from universities and research institutions. Parkwalk backs businesses from seed through growth, with an emphasis on defensible intellectual property in life sciences, medical technology, AI, quantum computing, advanced materials, clean technology and other deep technologies. As part of IP Group, it manages its own EIS products and university-linked funds, including the Imperial College Enterprise Funds. Imperial provides investment sourcing and evaluation, while Parkwalk manages the fund and makes investment decisions. Its Imperial College Innovation Fund I invested £250,000 in SERG Technologies’ 2022 seed round for Parkinson’s sensing technology. Current legal identity: Parkwalk is the trading name of Parkwalk Advisors Ltd, England and Wales company06925696, FCA-authorised manager FRN502237, and part of IP Group. Its public directory distinguishes the main Parkwalk team from three IP Capital institutional fundraising colleagues. Its products include evergreen Opportunities EIS investing and dated knowledge-intensive and university-linked EIS funds. Aggregate historical capital raised, assets under management, launch targets and university portfolio company financing are not individual fund closes.

Founded
2009
Type
Venture capital

Funds10

  • Oxford Venture Fund—

    Seventh Oxford-focused fund managed by Parkwalk, an Enterprise Investment Scheme vehicle investing in early-stage companies emerging from the University of Oxford research and commercialisation ecosystem. It seeks a diversified portfolio of research-led spinouts in AI, quantum computing, life sciences, digital health and hardware, with access to the Oxford University Innovation and Oxford Science Enterprises networks.

  • Parkwalk Knowledge Intensive EIS Fund V—

    Fifth HMRC-approved Knowledge Intensive Enterprise Investment Scheme fund managed by Parkwalk, investing in high-growth science and deep technology companies spun out of leading UK universities. Its strategy mirrors the evergreen Opportunities EIS Fund, with exposure to university-developed technologies and a single EIS5 tax certificate after qualifying investment deployment.

  • Northern Universities Venture Fund—

    Parkwalk-managed Enterprise Investment Scheme fund backing early-stage, intellectual-property-rich science and deep technology spinouts from the Northern Arc universities of Leeds, Liverpool, Manchester and Sheffield. The fund operates in collaboration with Northern Gritstone and targets quantum computing, AI, engineering biology, semiconductors, health technology and clean technology.

  • Parkwalk Knowledge Intensive EIS Fund IV—

    Fourth HMRC-approved Knowledge Intensive Enterprise Investment Scheme fund managed by Parkwalk, investing in high-growth science and deep technology companies originating from UK universities and research institutions. It mirrors the evergreen Opportunities EIS strategy and provides a portfolio of qualifying knowledge-intensive investments with a single EIS5 certificate.

  • University of Cambridge Enterprise Fund X£3M

    Tenth Cambridge Enterprise Fund, managed by Parkwalk in partnership with Cambridge Enterprise, investing in early-stage, research-intensive companies commercialising scientific and technological discoveries from the University of Cambridge ecosystem. It backs university spinouts, student-developed deep science companies and other research-led Cambridge businesses through the Enterprise Investment Scheme.

  • Imperial College Enterprise Fund III—

    Third Parkwalk-managed Imperial College Enterprise EIS fund investing in early-stage science and disruptive technologies emerging from Imperial research, students and its entrepreneurial ecosystem.

  • Parkwalk Knowledge Intensive EIS Fund III—

    Third HMRC-approved Knowledge Intensive Enterprise Investment Scheme fund managed by Parkwalk, backing high-growth science and deep technology businesses spun out of leading UK universities and research institutions. It follows the investment strategy of the evergreen Opportunities EIS Fund and offers investors a single EIS5 certificate after qualifying deployment.

  • University of Oxford Innovation Fund VI£3M

    Sixth University of Oxford Innovation Fund, an Enterprise Investment Scheme fund managed by Parkwalk in conjunction with Oxford University Innovation. It backs early-stage hard science and deep technology companies commercialising Oxford research and discoveries from the wider Oxford technology cluster, including AI, digital health and advanced industrial technologies.

Team

Alun Williams
Alun Williams

Parkwalk Advisors, Investment Director

—— – —
—— – —
Anne Dobrée
Anne Dobrée

Parkwalk Advisors, Investment Director

—— – —
David Townsend
David Townsend

Parkwalk Advisors, Institutional Team: Managing Director, IP Capital

—— – —
Greg Smith
Greg Smith

Parkwalk Advisors, Director, IP Group CEO

—— – —
Harriet Doherty
Harriet Doherty

Parkwalk Advisors, Director of Sales and Marketing

—— – —
John Pearson
John Pearson

Parkwalk Advisors, Chief Investment Officer

—— – —
Joyce Xie
Joyce Xie

Parkwalk Advisors, Institutional Team: Managing Director, Global Capital, Institutional Fundraising

—— – —
Kathy Samii
Kathy Samii

Parkwalk Advisors, Chief Operating Officer

—— – —
Martin Glen
Martin Glen

Parkwalk Advisors, Investment Director

—— – —

Operations and support

Chloe WoodacreChloe WoodacreHead of Investor Relations
Danielle AcuyDanielle AcuySenior Business & Data Analyst
George Van HornGeorge Van HornInstitutional Team: Vice President, IP Capital
Georgia DockerGeorgia DockerSenior Investor Relations Associate
Gordon LawsonGordon LawsonNon-Executive Chairman
Helen RedmondHelen RedmondChief Risk Officer
Lucy AllenLucy AllenMarketing Manager
Moray WrightMoray WrightChief Executive Officer
Olivia SmithOlivia SmithInvestor Relations Manager
Samiksha RaiSamiksha RaiInvestor Relations Assistant
Wisdom YemiWisdom YemiInvestment Associate

Co-investing

Boehringer Ingelheim Venture Fund
Chimera Partners
Oxford University Innovation Fund
Hostplus
Northern Gritstone

Investments